Search results
Author(s):
Nicolas Johner
,
Mehdi Namdar
,
Dipen Shah
Added:
3 years ago
Catheter ablation (CA) is a widely used first-line treatment for AF. Randomised controlled trials (RCTs) have shown its superiority to pharmacological treatment in terms of symptom control, rhythm control and mortality in selected patients; observational studies have also suggested a decreased risk of stroke.1,2 Pulmonary vein isolation (PVI) is the standard endpoint, but studies have reported…
View more
Author(s):
Maurizio Lunati
,
Ulrike Neuhold
,
Carina Blomström-Lundqvist
Start date:
Sep 11, 2018
View more
Atrial Fibrosis
Author(s):
Stylianos Tzeis
,
Dimitrios Asvestas
,
Panos Vardas
Added:
3 years ago
Article
Author(s):
Marco Bergonti
Added:
1 year ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more
Author(s):
Michael Timothy Brian Pope
,
Timothy Rider Betts
Added:
1 year ago
AF Ablation in HFpEF
Author(s):
Nicolas Johner
,
Mehdi Namdar
,
Dipen Shah
Added:
1 year ago
Article
Author(s):
Ksenia Sedova
,
Kirill Repin
,
Gleb Donin
,
et al
Added:
2 years ago
Author(s):
Andreas Metzner
,
Erik Wissner
,
Tina Lin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1.5–2 % of the general population.1 In the current clinical guidelines, catheter ablation is recommended in addition to drug-based antiarrhythmic therapy for patients suffering from symptomatic, drugrefractory AF. However, catheter ablation, if performed at an experienced centre, may also serve as first-line therapy in…
View more
Author(s):
Amar Trivedi
,
Bradley P Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM), a genetic sarcomeric disorder associated with myocyte disarray and scar deposition, is intimately linked to sudden cardiac death (SCD) due to malignant ventricular arrhythmias. In the first modern published description of the disease in 1958, Dr Donald Teare describes the case of a 14-year-old male who collapsed while being chased around his school’s playground…
View more
Author(s):
Peter H Waddingham
,
Pier D Lambiase
,
Amal Muthumala
,
et al
Added:
2 years ago